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Abstract
Professor Naoki Ikegami’s “Fee-for-service payment – an evil practice that must be stamped out” summarizes many 
of the failings of alternatives to fee-for-service (FFS) payment systems. His article also offers several suggestions 
for improving FFS systems. However, even powerful arguments against many of the alternatives to FFS, does not 
make a convincing argument for FFS systems. In addition, there are significant misunderstandings in Professor 
Ikegami’s presentation of and use of United States payment methods, the role of private vs. public insurance 
systems, and the increasing role of “accountable care organizations.”
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Professor Ikegami provides a careful and wide-ranging critique of the alternatives to fee-for-service (FFS) payment systems.1 Excellent arguments against the 
several alternatives to FFS, however, is not a necessarily a 
good defense of FFS, especially if the pro-FFS arguments are 
marred with several inaccuracies as applied to the United 
States, which is a key player in Professor Ikegami’s Editorial. 
Equally disconcerting, I see notable weaknesses in his 
proposals to improve FFS payment plans.
He starts with an excellent summary of the problems with 
FFS. Then, however, his presentation of the facts suggests lack 
of familiarity with the United States system, which he uses 
as a touchstone case. He says that “cost escalations, inequality 
and high administrative costs” are associated with each player 
“seeking to game (I think he means “gain”) at the expense of the 
other.” And he says that prices are set by the private health 
insurance plans. 
Let’s look at these statements: It is true that each discipline 
seeks to increase its reimbursements, but it is not a zero 
sum game, and costs continue to increase across the board. 
“My specialty is more deserving than your specialty” is not 
the cause of escalation.2,3 Also, and more important, while 
private insurance companies are active in setting some rates, 
they act to bring prices down, not up. They want to pay as 
little as possible for as few services as possible. Even more 
directly, the majority of medical cost prices—and usually 
the determination of what will be “covered”—are not set by 
private insurance companies, but rather covered services 
are primarily set by agencies of the federal government: 
Medicare and Medicaid.4,5 Professor Ikegami appears to 
neither comprehend nor incorporate the rule-setting 
functions of Medicare and Medicaid. Worse, he misses the 
overwhelming role of the big pharmacy industry—which 
has successfully lobbied congress to prevent many federal 
agencies from buying drugs at lower prices, and which also 
prevents importation of drugs from nations without captured 
regulatory processes, eg, most of the world except the 
United States. The cost of medications is a significant part of 
healthcare inflation, and is not a part of FFS. 
We shall not review his superb critiques of the alternative 
payment systems: health maintenance organizations (HMOs), 
pay-for-performance, diagnosis-related groups (DRGs), etc. 
But we single out his argument against pay-for-performance 
as especially cogent. 
We turn now to his recommendations for improving FFS. 
Alas, many of his recommendations have been tried and most 
have failed. 
1.	 He says that public service doctors or doctors in 
capitated fee systems use sometimes use FFS as an 
alternative income source, eg, some doctors have 
dual appointments and see FFS patients who receive 
faster service; others doctors avoid the public health 
system entirely. While true, that is not proof that FFS 
is a solution. Rather it shows that some public systems 
underpay their doctors, some public systems are poorly 
supported, some doctors are greedy, some want a 
higher-paying clientele, and some dislike bureaucracies. 
But FFS is a workaround to poor policy, not a solution 
for better care. Also, there are many big systems, like 
Kaiser, that pay doctors a fine wage and do not allow 
outside FFS services.6 
2.	 He says that FFS would improve if: (1) doctors were 
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obliged to mutually arrive at reasonable cost rates, 
perhaps assisted in their negotiations by experts, 
specialists, and proactive management; and, (2) we 
carefully defined each item and set clear standards for 
consultations, acuity levels, staffing levels, follow up 
care, etc. Unfortunately, the United States has tried this 
repeatedly, and the outcome is still a mess. It remains 
a political and financial conflict zone (as Professor 
Ikegami correctly notes). The Lutheran minister and 
sociologist Peter Berger one suggested that if cannibals 
and antivivisectionists where in a room together for 
a while, they would arrive at a compromise, such as 
it is not right to eat one’s relatives. Medical specialties 
have been at that negotiation room for decades and no 
compromise appears imminent.6
3.	 Professor Ikegami suggests that the cost of medical 
devices will be driven down by competition. That is 
simply not true in the United States, at least. Regulatory 
capture, restrictions on entry into the market, and other 
factors have had the opposite effect. 
4.	 Professor Ikegami writes that the introduction of new 
technologies will drive down prices. In the United States, 
the opposite has occurred. For large hospital systems, 
electronic health records (EHRs) cost hundreds of 
millions of dollars to purchase and billions of dollars to 
install.7 For ambulatory care and smaller hospitals the 
prices are of course lower, but still massively expensive. 
Magnetic resonance imagines (MRIs) are now common 
and cost many millions. 
He says that electronic billing will make the process more 
efficient and transparent. In the United States, it is absolutely 
not true. First, because of the interplay of government 
regulators, insurance companies, and several (often 
conflicting laws) the prices are completely non-transparent.8
For example, a hospital might have a listed charge for a service 
(say, inserting an artificial knee) of $35 000, but the various 
insurance companies will actually pay $4000, and the copays 
from individual patients will vary from $100 to $31 000.8,9 
Moreover, there will be additional fees from the 
anesthesiologist (with the same range of costs and payments), 
for operating room time, etc. In fact, most hospital bills are 
incomprehensible even to experts, and many are often flat out 
wrong.8,9 
Professor Ikagami raises many excellent points and is 
undoubtedly well-intended and knowledgeable about many 
national health systems. His critique of non-FFS systems is 
spot on. But his use of the United States as an example and as 
a source of lessons is problematic. In fact, the United States is 
moving increasingly toward “accountable care organization” 
payment plans, where the hospital or medical system assumes 
the cost and risk for all care. It is the exact opposite of FFS 
payment systems.10-13
In sum, his argument and hope for FFS as a solution to rising 
prices is not a convincing position.
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